UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000049136
Receipt number R000055970
Scientific Title Investigation of behavioral changes through the use of mailing test kits and health seminar
Date of disclosure of the study information 2022/10/06
Last modified on 2023/04/06 09:25:18

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Investigation of behavioral changes through the use of mailing test kits and health seminar

Acronym

Investigation of behavioral changes through the use of mailing test kits and health seminar

Scientific Title

Investigation of behavioral changes through the use of mailing test kits and health seminar

Scientific Title:Acronym

Investigation of behavioral changes through the use of mailing test kits and health seminar

Region

Japan


Condition

Condition

Healthy Adults

Classification by specialty

Not applicable

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To verify the effects on behavioral changes in lifestyle habits when adult women aged 40 to 59 use mailing test kits and participate health seminar.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Changes in health awareness and behavior before and after intervention

Key secondary outcomes

Urinary equol concentration


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Behavior,custom

Interventions/Control_1

1) Use the "SoyCheck" Equol test, a mailing test kit.
2) Participate in a seminar on menopausal women's health.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

40 years-old <=

Age-upper limit

59 years-old >=

Gender

Female

Key inclusion criteria

1. Persons who received a sufficient explanation of the purpose and contents of the exam, have the capacity to consent, applied with free will with sufficient understanding, and electronically agreed to participate with a written document
2. Women aged 40 to 59

Key exclusion criteria

1. Persons who have participated in other tests within the first month before the start of the test, or those who intend to participate in another exam after consenting to this exam
2. Persons who were judged as inappropriate for study participants by the principal investigator

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Hirohito
Middle name
Last name Ishikawa

Organization

Healthcare Systems Co., Ltd.

Division name

Clinical Research Department

Zip code

105-0004

Address

Nisshin Tatemono Shinbashi Bld. 7F, 4-6-15 Shinbashi, Minato-ku, Tokyo, JAPAN

TEL

03-6809-2722

Email

ishikawa@hc-sys.jp


Public contact

Name of contact person

1st name Natsuki
Middle name
Last name Asakawa

Organization

Healthcare Systems Co., Ltd.

Division name

Sales Planning Department

Zip code

105-0004

Address

Nisshin Tatemono Shinbashi Bld. 7F, 4-6-15 Shinbashi, Minato-ku, Tokyo, JAPAN

TEL

03-6809-2722

Homepage URL


Email

asakawa@hc-sys.jp


Sponsor or person

Institute

Healthcare Systems Co., Ltd.

Institute

Department

Personal name



Funding Source

Organization

Healthcare Systems Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

The Ethics Committee of Healthcare Systems Co., Ltd.

Address

Nisshin Tatemono Shinbashi Bld. 7F, 4-6-15 Shinbashi, Minato-ku, Tokyo, JAPAN

Tel

03-6809-2722

Email

soumu@hc-sys.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 10 Month 06 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

186

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2022 Year 10 Month 05 Day

Date of IRB

2022 Year 10 Month 05 Day

Anticipated trial start date

2022 Year 10 Month 20 Day

Last follow-up date

2023 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2022 Year 10 Month 06 Day

Last modified on

2023 Year 04 Month 06 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000055970


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name